These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18696099)

  • 1. Tolerability of N-chlorotaurine plus ammonium chloride in the rabbit and human eye--a phase 1 clinical study.
    Teuchner B; Schmid E; Ulmer H; Gottardi W; Nagl M
    Graefes Arch Clin Exp Ophthalmol; 2008 Dec; 246(12):1723-30. PubMed ID: 18696099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of inhaled N-chlorotaurine in the pig model.
    Geiger R; Treml B; Pinna A; Barnickel L; Prossliner H; Reinstadler H; Pilch M; Hauer M; Walther C; Steiner HJ; Giese T; Wemhöner A; Scholl-Bürgi S; Gottardi W; Arnitz R; Sergi C; Nagl M; Löckinger A
    BMC Pulm Med; 2009 Jul; 9():33. PubMed ID: 19602222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance of N-chlorotaurine, an endogenous antimicrobial agent, in the rabbit and human eye--a phase I clinical study.
    Nagl M; Miller B; Daxecker F; Ulmer H; Gottardi W
    J Ocul Pharmacol Ther; 1998 Jun; 14(3):283-90. PubMed ID: 9671436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study.
    Arnitz R; Stein M; Bauer P; Lanthaler B; Jamnig H; Scholl-Bürgi S; Stempfl-Al-Jazrawi K; Ulmer H; Baumgartner B; Embacher S; Geisler S; Gostner JM; Müllinger B; Kälz B; Nagl M
    Ther Adv Respir Dis; 2018; 12():1753466618778955. PubMed ID: 29857780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Chlorotaurine and ammonium chloride: an antiseptic preparation with strong bactericidal activity.
    Gottardi W; Arnitz R; Nagl M
    Int J Pharm; 2007 Apr; 335(1-2):32-40. PubMed ID: 17196346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic activity of N-chlorotaurine on Acanthamoeba spp.
    Fürnkranz U; Nagl M; Gottardi W; Köhsler M; Aspöck H; Walochnik J
    Antimicrob Agents Chemother; 2008 Feb; 52(2):470-6. PubMed ID: 18039920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute otitis externa: efficacy and tolerability of N-chlorotaurine, a novel endogenous antiseptic agent.
    Neher A; Nagl M; Appenroth E; Gstöttner M; Wischatta M; Reisigl F; Schindler M; Ulmer H; Stephan K
    Laryngoscope; 2004 May; 114(5):850-4. PubMed ID: 15126742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of N-chlorotaurine (NCT) in combination with NH4Cl against Trichomonas vaginalis.
    Fürnkranz U; Nagl M; Gottardi W; Duchêne M; Aspöck H; Walochnik J
    Int J Antimicrob Agents; 2011 Feb; 37(2):171-3. PubMed ID: 21074373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and efficacy of N-chlorotaurine in comparison with chloramine T for the treatment of chronic leg ulcers with a purulent coating: a randomized phase II study.
    Nagl M; Nguyen VA; Gottardi W; Ulmer H; Höpfl R
    Br J Dermatol; 2003 Sep; 149(3):590-7. PubMed ID: 14510994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-chlorotaurine, a natural antiseptic with outstanding tolerability.
    Gottardi W; Nagl M
    J Antimicrob Chemother; 2010 Mar; 65(3):399-409. PubMed ID: 20053689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model.
    Romanowski EG; Yates KA; Teuchner B; Nagl M; Irschick EU; Gordon YJ
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2021-6. PubMed ID: 16639011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Chlorotaurine shows high in vitro activity against promastigotes and amastigotes of Leishmania species.
    Fürnkranz U; Nagl M; Gottardi W; Matt U; Aspöck H; Walochnik J
    J Med Microbiol; 2009 Oct; 58(Pt 10):1298-1302. PubMed ID: 19541788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability of N-chlorotaurine in the bovine mammary gland.
    Huber J; Winter P; Gottardi W; Scholl-Bürgi S; Prokop W; Nagl M
    J Dairy Res; 2008 May; 75(2):248-56. PubMed ID: 18474144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis--a double-blind, randomized, phase-2 clinical trial.
    Teuchner B; Nagl M; Schidlbauer A; Ishiko H; Dragosits E; Ulmer H; Aoki K; Ohno S; Mizuki N; Gottardi W; Larcher C
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):157-65. PubMed ID: 15857282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Chlorotaurine Exhibits Fungicidal Activity against Therapy-Refractory Scedosporium Species and Lomentospora prolificans.
    Lackner M; Binder U; Reindl M; Gönül B; Fankhauser H; Mair C; Nagl M
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6454-62. PubMed ID: 26239996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis - a phase II pilot study.
    Nagl M; Teuchner B; Pöttinger E; Ulmer H; Gottardi W
    Ophthalmologica; 2000; 214(2):111-4. PubMed ID: 10720913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability of inhaled N-chlorotaurine in an acute pig streptococcal lower airway inflammation model.
    Schwienbacher M; Treml B; Pinna A; Geiger R; Reinstadler H; Pircher I; Schmidl E; Willomitzer C; Neumeister J; Pilch M; Hauer M; Hager T; Sergi C; Scholl-Bürgi S; Giese T; Löckinger A; Nagl M
    BMC Infect Dis; 2011 Aug; 11():231. PubMed ID: 21875435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of N-chlorotaurine in the guinea pig middle ear: a pilot study using an improved application system.
    Neher A; Nagl M; Prieskorn D; Mitchell A; Brown N; Schrott-Fischer A; Miller JM
    Ann Otol Rhinol Laryngol; 2004 Jan; 113(1):76-81. PubMed ID: 14763579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of N-chlorotaurine in chronic rhinosinusitis applied via yamik catheter.
    Neher A; Fischer H; Appenroth E; Lass-Flörl C; Mayr A; Gschwendtner A; Ulmer H; Gotwald TF; Gstöttner M; Kozlov V; Nagl M
    Auris Nasus Larynx; 2005 Dec; 32(4):359-64. PubMed ID: 16040219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability and safety of 0.1% diclofenac plus 0.3% tobramycin fixed-dose ophthalmic solution: a randomized, comparative, controlled study in healthy volunteers.
    Salvá P; Costa J; Andreu D; Notivol R; Martínez M
    Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):203-8. PubMed ID: 10389123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.